Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic preretinal membranes. An immunohistochemical study.

J A Jerdan, R G Michels, B M Glaser

    Archives of Ophthalmology (Chicago, Ill. : 1960)
    |February 1, 1986
    PubMed
    Summary

    Glial cells and collagen matrix are present in fibrovascular membranes from proliferative diabetic retinopathy patients. These findings offer insights into the cellular and structural components driving this vision-threatening condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness.

    Eye (London, England)·2014
    Same author

    Scleral outfolding for macular translocation.

    American journal of ophthalmology·2000
    Same author

    Clinicopathologic correlation of an untreated macular hole and a macular hole treated by vitrectomy, transforming growth factor-beta 2, and gas tamponade.

    American journal of ophthalmology·1996
    Same author

    Increased intraocular pressure after macular hole surgery.

    American journal of ophthalmology·1996
    Same author

    Intraocular tamponade duration and success of macular hole surgery.

    Retina (Philadelphia, Pa.)·1996
    Same author

    Reoperation after failed macular hole surgery.

    Retina (Philadelphia, Pa.)·1996

    Area of Science:

    • Ophthalmology
    • Cell Biology
    • Biochemistry

    Background:

    • Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss.
    • Fibrovascular membranes (FVMs) are key pathological features in PDR, contributing to complications like tractional retinal detachment.
    • Understanding the cellular and extracellular matrix composition of FVMs is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the cellular and matrix composition of fibrovascular membranes from patients with proliferative diabetic retinopathy.
    • To identify the presence and distribution of glial cells, collagen types, and associated attachment factors within these membranes.

    Main Methods:

    • Indirect immunofluorescence was employed to analyze fibrovascular membranes obtained during vitreous surgery.

    Related Experiment Videos

  • Specific antisera targeting collagen types I, III, IV, V, fibronectin, laminin, factor VIII (endothelial marker), and glial fibrillary acidic protein (GFAP) were used.
  • Immunofluorescence staining patterns were examined to determine the localization of these components.

    • Main Results:

    • Glial cells, identified by positive staining for glial-fibrillary acidic protein (GFAP), were present in 7 out of 10 specimens.
    • A well-developed vascular network surrounded by a dense collagenous matrix was observed in 4 out of 6 membranes.
    • The matrix showed strong staining for type I collagen and fibronectin, while type IV collagen and laminin staining were localized around blood vessels and the internal limiting membrane.

    Conclusions:

    • Fibrovascular membranes in proliferative diabetic retinopathy contain glial cells and a prominent collagenous matrix rich in type I collagen and fibronectin.
    • The findings suggest a complex interplay between cellular components and extracellular matrix in the pathogenesis of PDR.
    • Further research into these components may reveal novel therapeutic targets for PDR treatment.